Abstract
Aims Many cities have banned indoor smoking in public places. Thus, an updated recommendation for a breath carbon monoxide (CO) cut-off is needed that optimally determines smoking status. We evaluated and compared the performance of breath CO and semiquantitative cotinine immunoassay test strips (urine and saliva NicAlert®) alone and in combination. Design Cross-sectional study. Setting Urban drug addiction research and treatment facility. Participants Ninety non-treatment-seeking smokers and 82 non-smokers. Measurements Participants completed smoking histories and provided breath CO, urine and saliva specimens. Urine and saliva specimens were assayed for cotinine by NicAlert® and liquid chromatography-tandem mass spectrometry (LCMSMS). Findings An optimal breath CO cut-off was established using self-report and LCMSMS analysis of cotinine, an objective indicator, as reference measures. Performance of smoking indicators and combinations were compared to the reference measures. Breath CO ≥5 parts per million (p.p.m.) optimally discriminated smokers from non-smokers. Saliva NicAlert® performance was less effective than the other indicators. Conclusions In surveys of smokers and non-smokers in areas with strong smoke-free laws, the breath carbon monoxide cut-off that discriminates most effectively appears to be ≥5p.p.m. rather than the ≥10p.p.m. cut-off often used. These findings may not generalize to clinical trials, regions with different carbon monoxide pollution levels or areas with less stringent smoke-free laws.
Original language | English (US) |
---|---|
Pages (from-to) | 1325-1334 |
Number of pages | 10 |
Journal | Addiction |
Volume | 106 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2011 |
Externally published | Yes |
Keywords
- Assays
- Biomarker
- Carbon monoxide
- Cigarette smokers
- Cotinine
- Nicotine
- Non-smokers
- Saliva
- Urine
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Psychiatry and Mental health
- General Medicine